PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Long Term Debt Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual long term debt in 2023 was 19.39 Million USD , up 5.56% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly long term debt in 2024 Q2 was 21.68 Million USD , down -13.62% from previous quarter.
PT Kalbe Farma Tbk. reported annual long term debt of 18.36 Million USD in 2022, down -46.47% from previous year.
PT Kalbe Farma Tbk. reported annual long term debt of 34.31 Million USD in 2021, down -33.29% from previous year.
PT Kalbe Farma Tbk. reported quarterly long term debt of 25.09 Million USD for 2024 Q1, up 29.52% from previous quarter.
PT Kalbe Farma Tbk. reported quarterly long term debt of 21.68 Million USD for 2024 Q2, down -13.62% from previous quarter.

Annual Long Term Debt Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Long Term Debt of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	19.39 Million USD	5.56%
2022	18.36 Million USD	-46.47%
2021	34.31 Million USD	-33.29%
2020	51.44 Million USD	10.28%
2019	46.65 Million USD	158.19%
2018	18.06 Million USD	59.05%
2017	11.36 Million USD	15.74%
2016	9.81 Million USD	5.94%
2015	9.26 Million USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q3	21.08 Million USD	1473063.97%
2024 Q1	25.09 Million USD	29.52%
2024 Q2	21.68 Million USD	-13.62%
2023 Q3	12.4 Million USD	-17.11%
2023 FY	19.39 Million USD	5.56%
2023 Q2	14.96 Million USD	-19.07%
2023 Q1	18.49 Million USD	0.68%
2023 Q4	19.39 Million USD	56.31%
2022 Q4	18.36 Million USD	-29.42%
2022 FY	18.36 Million USD	-46.47%
2022 Q3	26.02 Million USD	-4.71%
2022 Q1	33.55 Million USD	-2.22%
2022 Q2	27.31 Million USD	-18.6%
2021 Q1	39.7 Million USD	0.0%
2021 FY	34.31 Million USD	-33.29%
2021 Q3	39.66 Million USD	0.75%
2021 Q4	34.31 Million USD	-13.49%
2021 Q2	39.37 Million USD	-0.85%
2020 FY	51.44 Million USD	10.28%
2019 FY	46.65 Million USD	158.19%
2018 FY	18.06 Million USD	59.05%
2017 FY	11.36 Million USD	15.74%
2016 FY	9.81 Million USD	5.94%
2015 FY	9.26 Million USD	0.0%

Peer Long Term Debt Comparison of PT Kalbe Farma Tbk.

Name	Long Term Debt	Long Term Debt Difference
AstraZeneca PLC	22.33 Billion USD	99.913%
Bristol-Myers Squibb Company PFD CONV 2	38.18 Billion USD	99.949%
CSPC Pharmaceutical Group Limited	107.05 Million USD	81.887%
Clarus Therapeutics Holdings, Inc.	- USD	-Infinity%
Novartis AG	20.03 Billion USD	99.903%